How do results from NSABP B-39 influence your practice for APBI compared to WBI in early stage breast cancer?

https://www.abstracts2view.com/sabcs18/view.php?nu=SABCS18L_568

Any concerns regarding toxicity with APBI?

Answer from: Radiation Oncologist at Academic Institution

With respect to clinical outcomes, the results of B-39 confirm what the data previously available demonstrated. APBI is an appropriate option for appropriately selected patients. A less than 5% recurrence at 10 years is excellent and paired with the updated RAPID results provide confidence that part...

Comments

Radiation Oncologist at Northeast Alabama Regional Medical Center
As initial disclaimer, I would only do EBRT APBI w...

Radiation Oncologist at Texas Oncology
I'm curious what everyone thinks about expanding t...

Radiation Oncologist at Northwestern University
I do not have these results. I will, however, make...

Radiation Oncologist at Cleveland Clinic
I would agree. I would not offer to 1-3 LN+ patien...

Radiation Oncologist at Texas Oncology
Any thoughts about those women with node negative ...

Radiation Oncologist at Northwestern University
Although less evidence-based, I am reluctant on th...

Radiation Oncologist at Cleveland Clinic
I cant speak to how many were on B-39 for these gr...

Please select the option that best describes you:

How do results from NSABP B-39 influence your practice for APBI compared to WBI in early stage breast cancer?

Related Questions